RIEMSER Arzneimittel AG invests in anwerina AG, a life science company specialized in the development and marketing of innovative orthopedic pharmaceutical and medical products.
VISCHER advises anwerina AG in the transaction. The team is led by partner Benedict F. Christ.
Share article on:
Service(s) included:
Get in touch with our authors and benefit from their expertise:
